|
JP2020172440A
|
|
Eye drop for treating dry eye
|
|
US2018320148A1
|
|
Acute Respiratory Distress Syndrome Therapeutic Agent
|
|
JP2018035075A
|
|
Dry eye therapeutic agent
|
|
AU2016227080A1
|
|
Quinuclidine derivative
|
|
WO2016104367A1
|
|
Functional dyspepsia therapeutic drug
|
|
WO2015122031A1
|
|
Optically active form of mepenzolate, and ameliorating agent for chronic obstructive pulmonary disease which contains same as active ingredient
|
|
US2015038719A1
|
|
Agent for Ameliorating Chronic Obstructive Pulmonary Disease
|
|
JP2013133323A
|
|
2-fluorophenyl propionic acid derivative
|
|
JP2013071902A
|
|
Heat shock protein expression inducer
|
|
JP2013053103A
|
|
Liver-accumulative nanoparticle having drug encapsulated therein
|
|
JP2012171883A
|
|
Nanoparticle containing prostaglandin i2 derivative
|
|
JP2012126671A
|
|
Hair tonic
|
|
WO2010064522A1
|
|
Inhalant comprising modified superoxide dismutase
|
|
JP2011084541A
|
|
Low molecular drug-containing nanoparticle
|
|
US2011262548A1
|
|
Novel prostaglandin e1 derivative and nanoparticle having the same encapsulated therein
|
|
WO2009128357A1
|
|
Bioactive protein-containing nanoparticle composition and method for producing the same
|
|
JP2010215527A
|
|
Ameliorating agent for chronic obstructive pulmonary disease
|
|
KR20100017714A
|
|
Low-molecule drug-containing nanoparticle having sustained release negatively charged group
|
|
WO2008105260A1
|
|
Therapeutic agent for ameliorating prognosis after lower limb amputation surgery
|
|
CN101583373A
|
|
Therapeutic agent for interstitial pneumonia
|
